GlassScriptPhysician profile
Karl W Strom
NPI 1831249275
$26,096.99
in general payments reported to CMS, 2019-2025
21 companies · $1,364 in 2025
The $1,364 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,212 · 2020: $13K · 2021: $2,003 · 2022: $3,604 · 2023: $1,883 · 2024: $1,364 · 2025: $1,364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,610.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $15,072.85 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $3,455.99 | 2019-2025 | Gore Seamguard Bioabsorbable Staple Line Reinforce, Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Ethicon US, LLC | $2,376.48 | 2019-2025 | Echelon Flex, Echelon Endopath, Echelon; Endopath |
| Ambu INC. | $1,487.35 | 2020-2025 | |
| Teleflex LLC | $970.87 | 2019-2025 | Titan Sgs Standard Gastric Stapler, Titan Sgs Bailout Chuck, Titan Sgs |
| Intra-Sana Laboratories | $845.95 | 2022-2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Intuitive Surgical, INC. | $705.60 | 2019-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $325.76 | 2021-2025 | Ligasure, Signia, Endo Stitch |
| Endo Pharmaceuticals INC. | $181.08 | 2019-2023 | Nascobal |
| Tela Bio, INC. | $179.96 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Stryker Corporation | $116.54 | 2025 | 1788 |
| Currax Pharmaceuticals LLC | $59.39 | 2023-2024 | Contrave |
| Olympus America INC. | $54.83 | 2023 | Visera Elite II Video System Center |
| Conmed Corporation | $50.22 | 2024 | Airseal |
| Takeda Pharmaceuticals U.S.A., INC. | $44.98 | 2019-2024 | Gattex |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $43.25 | 2019 | |
| Innocoll Pharmaceuticals Limited | $32.93 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $32.30 | 2019-2025 | Exparel |
| Novo Nordisk INC | $29.14 | 2022-2025 | Wegovy |
| Solventum Corporation | $16.27 | 2025 | Prevena, V.A.C. Veraflo |
| Polarityte, INC. | $15.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karl Strom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.